Collegium Pharmaceutical (COLL) stock is in focus as the company agrees to acquire ADHD drug Azstarys for up to $785M. Read more here.

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Third Avenue Management, a New York City-based investment firm, published its fourth-quarter 2025 investor letter for the ...

There are basically three ways students can earn COLL 300 credit: If you want to offer a COLL 300 opportunity of type 1, you do not need to seek EPC approval. Students who earn at least 3 credits in ...